ArticleAME case reports2026
Primary pulmonary myxoid sarcoma with detected
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary pulmonary myxoid sarcoma (PPMS) is an exceedingly rare low-grade malignant sarcoma characterized by the presence of Case Description: We report a case of a 52-year-old female patient who was admitted in May 2024 after a nodule was incidentally found in the right middle lobe during a routine health examination. Imaging studies revealed a solid nodule with mildly increased radiotracer uptake. The patient declined a biopsy and subsequently underwent uniportal video-assisted thoracoscopic surgery (UVATS) for right middle lobectomy. Intraoperative findings indicated a spherical nodule with significant adherence to the middle lobe vein. The frozen section analysis suggested a likely benign lesion, leading to the omission of lymph node dissection. Postoperative pathological examination confirmed the diagnosis of PPMS with Conclusions: PPMS is an extremely rare low-grade sarcoma with significant diagnostic implications due to its genetic characteristics. Surgical resection remains the primary treatment modality, though the potential for local recurrence or metastasis necessitates ongoing monitoring and further research to establish standardized treatment protocols and understand its biological behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.